3-(DIBUTYLAMINO)PROPYL 4-HYDROXYBENZOATE (HCL), 95%, 1g

2-chloro-N-[5-(tetrahydro-2-furanyl)-1,3,4-thiadiazol-2-yl]acetamide, 95.0%, 5g

1-Isopropyl-1H-pyrazole-5-carbaldehyde, 95.0%, 1g

(R)-1-CYCLOPROPYLETHANAMINE HCL, 95.0%, 10g

Relugolix, 99.67%, 1g

6-(Furan-2-yl)nicotinaldehyde, 98%, 250mg

5'-(4-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,4'',5-tricarboxylic acid, 97%, 500mg

GC capillary column ROTI®Cap-1701, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(S)-2-AMINO-3-(CARBOXYFORMAMIDO)PROPANOIC ACID, 95%, 100mg

Methyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

4-Isopropyl-1-methyl-2-nitrobenzene, 95.0%, 5g

N,N-Bis(2-chloroethyl)propan-1-amine hydrochloride, 97%, 250mg

5-bromo-3-nitro-N-(1-phenylethyl)-2-pyridinamine, 95.0%, 5g